Hosomi O, Takeya A, Kogure T, Iwai H, Yazawa S
Department of Legal Medicine, School of Medicine, Gunma University, Maebashi, Japan.
Biochim Biophys Acta. 1995 Oct 26;1259(1):18-22. doi: 10.1016/0005-2760(95)00129-z.
We have isolated a novel phospholipid/ganglioside-binding protein from rabbit sera or platelet-free plasma. Using an affinity chromatography of a commercial gel (Sephacryl S-series gel, Pharmacia) column and a preparative polyacrylamide gel electrophoresis, the protein can be easily purified. The protein agglutinates human red cells irrespective of the ABO blood types, and its hemagglutination reaction is specifically inhibited by some phospholipids (phosphatidylserine and phosphatidylglycerol) and ganglioside (N-acetylneuraminyl-galactosylglucosyl ceramide, GM3). The hemagglutination and its inhibition reactions are independent on any divalent cations (Ca2+, Mg2+, Mn2+, Ni2+). The protein seems to be assembled as multimers of disulfide-bonded molecular of 86 kDa and 59 kDa subunits.
我们从兔血清或无血小板血浆中分离出一种新型的磷脂/神经节苷脂结合蛋白。使用商业凝胶(Sephacryl S系列凝胶,Pharmacia)柱的亲和色谱法和制备性聚丙烯酰胺凝胶电泳,该蛋白可轻松纯化。该蛋白可凝集人类红细胞,与ABO血型无关,其血凝反应受到某些磷脂(磷脂酰丝氨酸和磷脂酰甘油)和神经节苷脂(N-乙酰神经氨酰-半乳糖基葡糖神经酰胺,GM3)的特异性抑制。血凝及其抑制反应不依赖于任何二价阳离子(Ca2+、Mg2+、Mn2+、Ni2+)。该蛋白似乎由86 kDa和59 kDa亚基的二硫键连接分子组装成多聚体。